• Home
  • About CSC
  • News
  • Photo Album
  • Advantage
  • Contact Us
  • Product
    • 6
    2025-8

    Li Li meets with secretary for social affairs and culture of Macao SAR

    21
    2025-7

    Policy Interpretation of Provisions on the Experimental Research of Narcotic Drugs and Psychotropic Substances

    11
    2025-7

    Chinese vice-premier calls for boosting basic pharmaceutical research, sci-tech innovation

    11
    2025-6

    Announcement of the National Medical Products Administration and National Health Commission on Issuing the 2025 Edition of the Pharmacopoeia of the People’s Republic of China (No. 29, 2025)

    11
    2025-6

    NMPA Announcement on Matters Related to the Implementation of the 2025 Edition of the Pharmacopoeia of the People's Republic of China (No. 32, 2025)

    11
    2025-6

    Announcement of the National Medical Products Administration and National Health Commission on Issuing the 2025 Edition of the Pharmacopoeia of the People’s Republic of China (No. 29, 2025)

    11
    2025-6

    NMPA Announcement on Issuing the Pharmaceutical Excipients Annex and Pharmaceutical Packaging Materials Annex of the Good Manufacturing Practice for Drugs (2010 Revision) (No.1, 2025)

    19
    2025-2

    NMPA Announcement on Issuing the Interim Provisions on the Management of Designated Domestic Responsible Persons by Overseas Marketing Authorization Holders